- Home
- AMLX vs XPEL Comparison
AMLX vs XPEL Comparison
Compare AMLX & XPEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- XPEL
- Stock Information
- Founded
- AMLX 2014
- XPEL 1999
- Country
- AMLX United States
- XPEL United States
- Employees
- AMLX N/A
- XPEL N/A
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- XPEL Industrial Specialties
- Sector
- AMLX Health Care
- XPEL Industrials
- Exchange
- AMLX Nasdaq
- XPEL Nasdaq
- Market Cap
- AMLX 1.3B
- XPEL 1.2B
- IPO Year
- AMLX 2022
- XPEL N/A
- Fundamental
- Price
- AMLX $14.79
- XPEL $44.19
- Analyst Decision
- AMLX Strong Buy
- XPEL
- Analyst Count
- AMLX 7
- XPEL 0
- Target Price
- AMLX $17.43
- XPEL N/A
- AVG Volume (30 Days)
- AMLX 1.5M
- XPEL 375.1K
- Earning Date
- AMLX 11-06-2025
- XPEL 11-05-2025
- Dividend Yield
- AMLX N/A
- XPEL N/A
- EPS Growth
- AMLX N/A
- XPEL N/A
- EPS
- AMLX N/A
- XPEL 1.69
- Revenue
- AMLX N/A
- XPEL $461,460,000.00
- Revenue This Year
- AMLX N/A
- XPEL $12.54
- Revenue Next Year
- AMLX N/A
- XPEL $10.52
- P/E Ratio
- AMLX N/A
- XPEL $26.17
- Revenue Growth
- AMLX N/A
- XPEL 10.29
- 52 Week Low
- AMLX $2.60
- XPEL $24.25
- 52 Week High
- AMLX $16.96
- XPEL $47.23
- Technical
- Relative Strength Index (RSI)
- AMLX 60.27
- XPEL 77.86
- Support Level
- AMLX $11.93
- XPEL $39.61
- Resistance Level
- AMLX $15.09
- XPEL $41.20
- Average True Range (ATR)
- AMLX 1.00
- XPEL 1.95
- MACD
- AMLX 0.14
- XPEL 0.54
- Stochastic Oscillator
- AMLX 89.70
- XPEL 94.67
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
About XPEL XPEL Inc.
XPEL Inc is a supplier of protective films, coatings, and related services to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from the sale of automotive products and related services while the remainder of its revenue is derived from non-automotive products including architectural window film and marine and flat surface protection films. The majority of revenue is derived from the United States.